InvestorsHub Logo
Followers 195
Posts 24755
Boards Moderated 0
Alias Born 04/03/2010

Re: HappyLibrarian post# 401242

Friday, 09/10/2021 2:23:46 PM

Friday, September 10, 2021 2:23:46 PM

Post# of 706533
Yes, that is from your perspective and you never let up on the darkness and gloom and why you hold, given your unending outlook of gloom since .14 and before that, makes no sense to me.

It is easy to paint a horrible and dark, terrible picture and one that is incredibly better. I typically don’t spend too much time painting either picture though I do directly critique the doom and gloomers, as you know from personal experience.

I do not feel or see the current situation in the faux dark light you see it in, but you of course have every right to a dark opinion. Not everyone is of the same mind. That it all comes together at a moment before anticipated news that has been likely for some time on multiple fronts, and that timelines are often not met and sometimes you don’t want to wait for the publication that will simply take too long, these are common complaints but usually immaterial in the end.

The implication that they never complete anything, or never meet expectations is simply not true. The publication of blinded results was extremely impressive. And I expect these final results will confirm and likely better those results. But I believe that they are looking for more than basic OS data, they are looking for data that will help them on many levels and in the future with regard to biomarkers I expect. And those considerations, given when the trial started, may be more complicated, may have delayed parts of the effort, which I think is now focused on a future license for a general cancer vaccine.

Additionally, I think they want to be well on their way toward expedited approval, and the manufacturing part, they know, we all know, is a complicated part of that process.

The publication is for objective vindication. They may be less likely to just go for any publication and may be trying harder and that may require addressing rivals who are reviewing for publication. It is hard to know, but they likely have little control over that process. And who knows, in the end they could go with a different publication than they maybe hoped because of the delays and anxieties around them. Who knows.

None of it is bothering me. I consider this prime time. Not to say I don’t want it yesterday if that could happen. But I think NOW is prime time, the coming weeks and few months. And their last PR on manufacturing says that is what they HOPE as well. But no one can know for sure, not even the top executives at NWBO. Much of what happens is simply not 100% in their hands. In fact, it appears to me that a lot less in on their hands than people presume.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News